Cited by 505Statistical Methods in Clinical TrialsAdvanced Causal Inference TechniquesMeta-analysis and systematic reviews

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Open access

Kent, David M, Rothwell, Peter M, Ioannidis, John PA, Altman, Doug G, Hayward, Rodney A·2010·Trials

DOI 10.1186/1745-6215-11-85PMC PMC2928211

Open this paper in CoChat — free account Open PDF

Abstract

Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the trial population, such that the balance between treatment risks and benefits may differ substantially between large identifiable patient subgroups; the "average" benefit observed in the summary result may even be non-representative of the treatment effect for a typical patient in the trial. Conventional subgroup analyses, which examine whether specific patient characteristics modify the effects of treatment, are usually unable to detect even large variations in treatment benefit (and harm) across risk groups because they do not account for the fact that patients have multiple characteristics simultaneously that affect the likelihood of treatment benefit. Based upon recent evidence on optimal statistical approaches to assessing HTE, we propose a framework that prioritizes the analysis and reporting of multivariate risk-based HTE and suggests that other subgroup analyses should be explicitly labeled either as primary subgroup analyses (well-motivated by prior evidence and intended to produce clinically actionable results) or secondary (exploratory) subgroup analyses (performed to inform future research). A standardized and transparent approach to HTE assessment and reporting could substantially improve clinical trial utility and interpretability.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/1745-6215-11-85

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020124 · Cited by 10,505
Self-citation
Validation of a combined comorbidity index
Charlson, M., Szatrowski, T. P., Peterson, J., & Gold, J. (1994) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)90129-5 · Cited by 6,587
Validation of Clinical Classification Schemes for Predicting Stroke: Results From the National Registry of Atrial Fibrillation
Gage, B. F., Waterman, A. D., Shannon, W., Boechler, M., Rich, M. W., & Radford, M. J. (2001) · JAMA · doi:10.1001/jama.285.22.2864 · Cited by 4,832
Why Most Published Research Findings Are False
Ioannidis, J. P. A. (2005) · CHANCE · doi:10.1080/09332480.2005.10722754 · Cited by 4,702 · cited 1×
“Additionally, because conventional subgroup analyses involve multiple comparisons and involve splitting the overall sample to smaller sub-samples, they are both under-powered for detecting genuine subgroup effects (prone to false-negatives), and even more commonly they are prone to false positive findings [25-31].”
BackgroundSelf-citation
The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI
Antman, E. M., Cohen, M. C., Bernink, P. J. L. M., McCabe, C. H., Horacek, T., Papuchis, G., Mautner, B., Corbalán, R., Radley, D. R., & Braunwald, E. (2000) · JAMA · doi:10.1001/jama.284.7.835 · Cited by 3,221
Adjusting for multiple testing—when and how?
Bender, R., & Lange, S. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00314-0 · Cited by 3,168
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
Yusuf, S., Zucker, D. M., Passamani, E. R., Peduzzi, P. N., Takaro, T., Fisher, L. D., Kennedy, J. W., Davis, K. B., Killip, T., Norris, R. M., et al. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91963-1 · Cited by 2,125
Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban
Cannon, C. P., Weintraub, W. S., Demopoulos, L. A., Vicari, R. M., Frey, M. J., Lakkis, N. M., Neumann, F., Robertson, D. H., DeLucca, P. T., DiBattiste, P. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106213442501 · Cited by 2,093
Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial
(2005) · The Lancet · doi:10.1016/s0140-6736(05)67660-x · Cited by 1,858
West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials
(1996) · The Lancet · doi:10.1016/s0140-6736(96)04292-4 · Cited by 1,564

Show all 72 references

Sorted by citations

Items 401–500 of 505

Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk
Davidoff, F., & Rosenberg, I. H. (2014) · Annals of Internal Medicine · doi:10.7326/l14-5018-3 · Cited by 2
Re: Selecting Optimal Subgroups for Treatment Using Many Covariates
Kent, D. M., & Klaveren, D. V. (2019) · Epidemiology · doi:10.1097/ede.0000000000001156 · Cited by 2
Self-citation
Differential Use of Glycoprotein IIb/IIIa Inhibitors with Bivalirudin in Patients with STEMI Undergoing PCI: A Systematic Review and Meta-Analysis
Mushahid, H., Shah, S., Farhan, S. H., Shuja, M. H., Balasingam, K., Siddiqui, A. A., Hameed, I., Akram, K., Mushahid, S., & Usman, M. (2024) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-024-00636-6 · Cited by 1
Precision medicine evaluation of heterogeneity of treatment effect for a time-to-event outcome with application in a trial of Initial treatment for people living with HIV
Zheng, Y., Currier, J., & Hughes, M. D. (2025) · Clinical Trials · doi:10.1177/17407745251338558 · Cited by 1
Heterogeneity in Treatment Effects of Reduced Versus Standard Dose of Cabazitaxel in Metastatic Castration‐Resistant Prostate Cancer
Fukuokaya, W., Mori, K., Yanagisawa, T., Ito, K., Urabe, F., Rajwa, P., Shariat, S. F., Kimura, T., & Hirakawa, A. (2026) · Cancer Medicine · doi:10.1002/cam4.71507 · Cited by 1
Bringing Regulatory-Style Benefit-Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision-Making.
García-Zamora, S., da Silva, F. T., Labudovic, I., & Vicco, M. H. (2026) · Journal of Evaluation In Clinical Practice · doi:10.1111/jep.70558 · Cited by 1
Averaged versus individualized: pragmatic N-of-1 design as a method to investigate individual treatment response
Serpico, D., & Maziarz, M. (2023) · European Journal for Philosophy of Science · doi:10.1007/s13194-023-00559-0 · Cited by 2
Antidepressant Medication Use for Treatment of Chronic Ocular Pain
Lott, L. B. D., Khan, N., Woodward, M. A., Clauw, D. J., & Galor, A. (2024) · Cornea · doi:10.1097/ico.0000000000003646 · Cited by 1
Which intervention works for whom: Identifying pre-treatment characteristics that predict who will benefit from a specific alcohol text message intervention from a randomized trial
Chung, T. A., Suffoletto, B. P., & Bhurosy, T. (2024) · Journal of Substance Use and Addiction Treatment · doi:10.1016/j.josat.2024.209562 · Cited by 1
Advancing statistical methodologies in traditional Chinese medicine and acupuncture research: Enhancing transparency and analytical sophistication
MacDonald, R., Bai, D., ZHANG, Z.-H., Huang, N., Gao, J.-Y., Zhang, X., Fan, L., Shu-min, C. H. E. N., & Lu, L. U. O. (2026) · 世界针灸杂志：英文版 · doi:10.1016/j.wjam.2026.02.004 · Cited by 1
Patient-profiled treatment responses in a large hypertension trial: a posthoc analysis of the INSIGHT study
de Leeuw, P. W., Mancia, G., Palmer, C., Ruilope, L. M., Schalm, S. W., & Brown, M. J. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004284 · Cited by 1
Multidimensional Recovery Trajectories Following Physiotherapy with or Without Pain Education in People with Chronic Low Back Pain
Alalawi, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15062320 · Cited by 1
Coronary collateral circulation and mortality in ST-elevation myocardial infarction undergoing primary PCI: an updated systematic review and meta-analysis of 18,443 patients
Biswas, S. K., Srivastava, Y., & Hamadttu, A. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-05740-w · Cited by 1
Fatigue in Neurological Rehabilitation: Why Brain Diversity and Population Diversity Matter
Rudroff, T. (2026) · Neurorehabilitation and neural repair · doi:10.1177/15459683261481762 · Cited by 1
Registration of epidemiological studies: benefits and risks
Ellenberg, S. S., & Lewis, J. D. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2111 · Cited by 1
Improving Prognostic Web Calculators: Violation of Preferential Risk Independence
Alemi, F., Levy, C. R., Citron, B. A., Williams, A. R., Pracht, E. E., & Williams, A. E. (2016) · Journal of Palliative Medicine · doi:10.1089/jpm.2016.0126 · Cited by 1
Clinical Prediction Models of Patient and Graft Survival in Kidney Transplant Recipients: A Systematic Review and Validation Study
Singh, S. K. S. (2016) · TSpace (University of Toronto) · Cited by 1
Development of Personalized Medicine
Jain, K. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-62080-6_22 · Cited by 1
Observation of the Therapeutic Effect of Dual Antiplatelet Therapy with Aspirin and Clopidogrel on the Incidence, Characteristics, and Outcome in Acute Ischemic Stroke Patients with Cerebral Microbleeds at a Teaching Hospital, China
Jia, S., Liu, X., Qu, H., & Jia, X. (2024) · International Journal of General Medicine · doi:10.2147/ijgm.s459323 · Cited by 1
Heterogeneity in Treatment Effects in the Reduction of Dietary Sodium to Less Than 100 mmol in Heart Failure (SODIUM-HF): A Secondary Post Hoc Analysis
Zampieri, F. G., Rathwell, S., McAlister, F. A., Ross, H. J., Escobedo, J., Saldarriaga, C., Colin-Ramírez, E., Troughton, R. W., Macdonald, P. S., Alemayehu, W. G., et al. (2025) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2025.01.027 · Cited by 1
Heterogeneous treatment effects of stress ulcer prophylaxis among ICU patients at risk for gastrointestinal bleeding
Xie, Y., Yan, Y., Hong, Q., Zheng, H., Cao, L., Li, X., Liu, S., & Chen, H. (2025) · BMC Medicine · doi:10.1186/s12916-025-04038-6 · Cited by 1
Doubly Robust Estimators for Heterogeneous Treatment Effects in Heteroskedastic Survival Data
Yang, Y., Hu, W., Liao, Z., & Chen, F. (2025) · Statistics in Medicine · doi:10.1002/sim.70301 · Cited by 2
Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations
Segal, J. B., & on behalf of the PRIORITIZE HCV Study Group (2020) · Clinical Trials · doi:10.1177/1740774520941257 · Cited by 1
The assessment of heterogeneity is mandatory in clinical trials and systematic reviews
Bender, R., Koch, A., Skipka, G., Kaiser, T., & Lange, S. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.10.002 · Cited by 1
Clinical Trial Subgroups
Spertus, J. A. (2011) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.111.961128 · Cited by 1
Finding and assessing treatment effect sweet spots in clinical trial dataPreprint
Craig, E., Redelmeier, D. A., & Tibshirani, R. J. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2011.10157 · Cited by 1
Concentration of Benefit index: A threshold-free summary metric for quantifying the capacity of covariates to yield efficient treatment rulesPreprint
Sadatsafavi, M., Mansournia, M. A., & Gustafson, P. (2020) · arXiv (Cornell University) · doi:10.1002/sim.8481 · Cited by 10
Skills, Knowledge, and Prediction
Accad, M. F. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.04.007
Managing physician lipid management: a population wide, risk-based decision support approach
Rubenstein, L. V. (2015) · Israel Journal of Health Policy Research · doi:10.1186/s13584-015-0032-9
On the crossroads of cardiovascular disease and cancer : shared risk factors and treatment strategies
van Kruijsdijk, R. C. M. (2014) · Utrecht University Repository (Utrecht University)
From mechanism to empiricism: the evolution of heterogeneity of treatment effects
McElwee, N. E., & Girman, C. J. (2014) · Journal of Comparative Effectiveness Research · doi:10.2217/cer.14.49
Are cardiovascular trial results systematically different between North America and Europe? A study based on intra-meta-analysis comparisons Est-ce que les résultats des essais en pathologie cardiovasculaire diffèrent systématiquement entre l'Amérique du Nord et l'Europe ? Une étude basée sur des comparaisons à l'intérieur de méta-analyses
Bowater, R. J., Hartley, L., & Lilford, R. J. (2015)
Development of Clinical Practice
Craske, M. G., Crawford, K. A., Kivlahan, D. R., Magnavita, J. J., Ollendick, T. H., Sexton, T. L., Bufka, L. F., Galper, D. I., & Kurtzman, H. S. (2014)
Rebuttal From Dr Courtright
Courtright, K. R. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.01.031
Rebuttal From Dr Tillotson
Tillotson, G. (2016) · CHEST Journal · doi:10.1016/j.chest.2016.01.027
Rehabilitation while standing.
Vannini, A. M. (2000) · PubMed
Heterogeneity of therapeutic effects
Trampisch, H. J., Rudolf, H., & Lange, S. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.034
Very Tentative Introductory Syllabus
DiNardo, J. (2014)
Encouraging Recruitment of Under-Represented Groups in Clinical Studies: A Sponsor's Perspective
Stennett, S. (2022) · Digital Archive @ GSU · doi:10.57709/10116725
For Whom Is the Treatment Effective? an Atheoretic Inductive Approach to Identifying Response Heterogeneity
Long, M. C. (2015) · 2015 Fall Conference: The Golden Age of Evidence-Based Policy
Which Patients With Ischemic Stroke and Insulin Resistance May Benefit From Pioglitazone Hydrochloride?
Hankey, G. J. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.2142
Whom to Treat for High Blood Pressure—Time for a Precision Approach
Moran, A. E., Pletcher, M. J., & Bibbins-Domingo, K. B. (2018) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.7853
Searching for an Optimal Systolic Blood Pressure Target: A Balance of Benefits and Risks
Leung, A. A. C., & Padwal, R. S. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2018.08.037
Novel metrics for quantifying the capacity of subgroup-defining variables to yield efficient treatment rulesPreprint
Sadatsafavi, M., Mansournia, M. A., & Gustafson, P. (2019) · arXiv (Cornell University)
Supervised variable selection in randomised controlled trials prior to exploration of treatment effect heterogeneity: an example from severe malariaPreprint
Wu, C., & Holmes, C. C. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1901.03531
Patent foramen ovale: the known unknowns
Thaler, D. E., & Gans, S. (2019) · EuroIntervention · doi:10.4244/eijv14i13a244
Advancements in Probabilistic Machine Learning and Causal Inference for Personalized Medicine
Lorenzi, E. (2019)
Why clinical trials may not help patients make treatment decisions: results from focus group discussions with 22 patients
Concannon, T. W., Lundquist, C. M., Lutz, J. S., Kent, D. M., & Paulus, J. K. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0033
Self-citation
Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments
Gera, R. G., & Friede, T. (2023) · Biometrical Journal · doi:10.1002/bimj.202000326
Bayesian Modeling in Personalized Medicine with Applications to N-of-1 Trials
Liao, Z. (2021) · doi:10.7916/d8-7gmp-5v08
Effect Modification of Interventions. Bridging the Gap Between Clinical Studies and the Individual Patient
Schmidt, A. F. (2014) · Utrecht University Repository (Utrecht University)
Personalizing Medicine
Duan, T., & Basu, S. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108872188.006
Personalized Medicine
Suen, S., Scheinker, D., & Enns, E. A. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108872188.004
Comparative Effectiveness of Direct Admission & Admission through Emergency Departments for Children: A Randomized Stepped Wedge Study ProtocolPreprint
Leyenaar, J. K., McDaniel, C. E., Acquilano, S. C., Schaefer, A., BRUCE, M. L., & O’Malley, A. J. (2020) · Research Square · doi:10.21203/rs.3.rs-52189/v1
Advancing Understanding and Appropriate Use of Methods in PCOR
(2017) · doi:10.25302/67.2017.4
Faculty Opinions recommendation of Intensive Glucose Control in Patients with Type 2 Diabetes - 15-Year Follow-up.
Aronow, W. S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735910698.793566214
Analytical Approaches for Post-Authorization Safety Studies
(2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809217-0.00005-2
Identifying and Addressing Evidence Gaps in PCOR
(2017) · doi:10.25302/67.2017.2
Development and verification of a nomogram for the prediction of coronary heart disease in the Chinese Guangxi Zhuang populationPreprint
Meng, Y., Chen, C., Jiang, Z., Chen, K., Ouyang, J., Wang, H., & Huang, J. (2022) · Research Square · doi:10.21203/rs.3.rs-1681671/v1
Prognostic and treatment effect modeling in medical research
Hoogland, J. (2023) · doi:10.33540/1789 · Cited by 1
Network and covariate adjusted response‐adaptive design for binary response
Mei, H., Xie, J., Qin, Y., & Li, Y. (2023) · Statistics in Medicine · doi:10.1002/sim.9915
Determining the Association Between the Origin of Sepsis and the Severity of Sepsis in Intensive Care Unit (ICU) Patients Using Acute Physiology and Chronic Health Evaluation (APACHE) IV
Arumairaj, A. J., Habtes, I., Park, H., Valencia-Manrique, J. C., Arzu, J. L., Mattana, J., Chaudhari, S., Trenard, N., & Newman, T. (2024) · Cureus · doi:10.7759/cureus.54653
Increasing Importance of Patients-generated Real World Data for Healthcare Policy Decisions about Medicinal Products - Volume II
(2024) · Frontiers research topics · doi:10.3389/978-2-8325-4855-4
References
Pawson, R. (2024) · Edward Elgar Publishing eBooks · doi:10.4337/9781035321100.00053
Lies, damned lies, and statistical populations
Raymond, J., & Darsaut, T. E. (2024) · Neurochirurgie · doi:10.1016/j.neuchi.2024.101610
Treatment allocation in ophthalmological randomised-control trials (TAO-RCT): A cross-sectional meta-research study
Thirunavukarasu, A. J., Guru, S., Rocha, H., & Sekhon, C. S. (2025) · Eye · doi:10.1038/s41433-025-03922-y
A commentary on “Long-term outcomes of single-incision laparoscopic surgery for colorectal cancer: a single-center, open label, randomized controlled trial”
Huang, J., & Lin, J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000003057
Reaching Individualized Optimal Oxygen Therapy in Mechanically Ventilated Patients—Reply
Grocott, M. P. W., Mouncey, P. R., & Martín, D. (2025) · JAMA · doi:10.1001/jama.2025.14080
Letter to the editor: Immediate “sipping” vs. delayed oral fluid intake after extubation: A randomized controlled trial
Zhou, S., Zhao, Y., Mao, H., & Wang, G. (2025) · Journal of Critical Care · doi:10.1016/j.jcrc.2025.155297
Additional file 3 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196715
Additional file 4 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196718
Additional file 2 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196712
Additional file 6 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196724
Additional file 5 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196721
Additional file 1 of Graphing and reporting heterogeneous treatment effects through reference classes
Watson, J. A., & Holmes, C. C. (2020) · Figshare · doi:10.6084/m9.figshare.12270440
Additional file 1 of Finding associations in a heterogeneous setting: statistical test for aberration enrichment
Mezlini, A. M., Das, S., & Goldenberg, A. (2021) · Figshare · doi:10.6084/m9.figshare.14478611
Additional file 1 of Estimating individualized treatment effects from randomized controlled trials: a simulation study to compare risk-based approaches
Rekkas, A., Rijnbeek, P. R., Kent, D. M., Steyerberg, E. W., & van Klaveren, D. (2023) · Figshare · doi:10.6084/m9.figshare.22619365
Self-citation
Additional file 1 of Feasibility and efficacy of a decision aid for emergency department patients with suspected ureterolithiasis: protocol for an adaptive randomized controlled trial
Schoenfeld, E. M., Poronsky, K. E., Westafer, L. M., DiFronzo, B. M., Visintainer, P., Scales, C. D., Hess, E. P., & Lindenauer, P. K. (2021) · Figshare · doi:10.6084/m9.figshare.14196709
Comment on “Intravenous Versus Inhaled Milrinone in Patients with Known Pulmonary Hypertension Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis
Rashid, D., & Zehra, S. (2026) · Annals of Cardiac Anaesthesia · doi:10.4103/aca.aca_223_25
Strategies to improve regional representation in heart failure randomized controlled clinical trials
Baudry, G., Monzo, L., Newton, R. A. V., Li, G., Petrie, M. C., Girerd, N., Mebazaa, A., Garaygordobil, D. A., Mocumbi, A. O., Rohwedder, K., et al. (2026) · Nature Cardiovascular Research · doi:10.1038/s44161-026-00779-6
Comparison of disease risk score methods to study treatment effect heterogeneity: a simulation study
Thelen, H. E., Yang, W., Hennessy, S., Cohen, J. B., Guo, W., & Miano, T. A. (2026) · American Journal of Epidemiology · doi:10.1093/aje/kwag050
Evaluating weight-adjusted waist index as a risk factor for chronic obstructive pulmonary disease: A cross-sectional analysis of NHANES data
Li, Y., & Li, B. (2026) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/207571
The Use of Baseline Score in Cost-Effectiveness Modeling of Competing Interventions
Hamza, T., Chalkou, K., Pellegrini, F., Lorscheider, J., Kühle, J., Meier, N., Pletscher, M., Egger, M., Salanti, G., Manca, A., et al. (2026) · Value in Health · doi:10.1016/j.jval.2026.03.2245
Heterogeneity of treatment effect? What baseline prognostic factors tell us about immunotherapy benefit
Lee, C. K., & Simes, R. J. (2026) · JNCI Cancer Spectrum · doi:10.1093/jncics/pkag031
Heterogeneous Treatment Effect for Targeted Temperature Management After Cardiac Arrest: A Causal Machine Learning AnalysisPreprint
Raskin, M. B., Karhu-Leperd, I., Harris, C., Pirracchio, R., Lascarrou, J.-B., & Stevens, R. D. (2026) · medRxiv · doi:10.64898/2026.05.04.26352388
Challenging a “Gold Standard” in Rehabilitation Research: The Limits of Outcome-Centered Trials in Pain Science
Moreira, M. F., & Oliveira, M. A. P. (2026) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2026.05.005
A dynamic perspective on clinical treatment evaluation using dynamic structural equation modeling
He, S., & Lee, W. (2026) · BMC Medical Research Methodology · doi:10.1186/s12874-026-02921-1
Energetic stability states in mast cell activation syndrome: operationalizing reserve, pressure, and threshold collapse
Tellier, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1865449
Vaccine Mandates and Evidence-Based Medicine: A Narrative Review
Liester, M. B. (2026) · Journal of Independent Medicine · doi:10.71189/jim/2026/v02n04a05
A new mathematical analysis of randomized trials applied to critical care syndromes: a review
Lynn, L. (2026) · Patient Safety in Surgery · doi:10.1186/s13037-026-00499-7
Observational analyses in cardiovascular device evaluation, methods, applications, and challenges: A comprehensive review
Sandeep, B., Cheng, H., Liu, X., Huang, X., Yan, Y., Jiang, F., Xiong, D., Wu, Q., Gao, K., & Xiao, Z. (2026) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2026.103398
A Transzlációs Idegtudományi Nemzeti Laboratórium STROKE adatplatformjának és az erre épülő klinikai vizsgálatoknak az összefoglalása és következtetései
Schranz, D., Fehér, G., Jozifek, E. J., Karádi, Z. N., Bosnyák, E., & Szapáry, L. (2026) · Orvosi Hetilap · doi:10.1556/650.2026.33600
When Surgical Innovation Outpaces Evidence: Does Modern Maximal Resection Require Re-Evaluation of Postoperative Radiotherapy in Glioblastoma?
Tykocki, T. (2026) · Medical Sciences · doi:10.3390/medsci14030404
Modeling Individual Patient Outcomes After Interatrial Shunt Treatment in Heart Failure With Reduced and Preserved Ejection Fraction: The RELIEVE-HF Trial
Stone, G. W., Lindenfeld, J. M., Zile, M. R., Anker, S. D., Rodés‐Cabau, J., Snyder, C., Kar, S., Pfeiffer, M. P., Bayés‐Genís, A., Bax, J. J., et al. (2026) · Circulation Heart Failure · doi:10.1161/circheartfailure.125.014100
Human-Centered AI Healthcare Interventions and Quality of Life in Older Adults Living Alone: A Systematic Review and Meta-Analysis
Jeong, M.-A., & Kim, S.-D. (2026) · Applied Sciences · doi:10.3390/app16167899
Prediction Error Masquerades as Individual Treatment Response: A Placebo-Controlled Falsification Study in Pooled ALS TrialsPreprint
Ewing, M. T. (2026) · Research Square · doi:10.21203/rs.3.rs-10898606/v1
Emotional Memory Modulation
Pais, M. (2026) · Radboud University Press eBooks · doi:10.54195/9789465153001
Subgroup analyses in stepped-wedge cluster randomized trials: a systematic review of statistical practice and reporting from 2016 to 2023
Tong, G., Li, C., Wang, H., Fang, X., Liu, R., Zeng, Y., Sun, Q., Ouyang, Y., Ryan, M. M., Davis‐Plourde, K. L., et al. (2026) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2026.112512
Comment on: “Impact of Concomitant Grade I Degenerative Spondylolisthesis on Clinical and Radiographic Outcomes Following Biportal Endoscopic Versus Microscopic Laminectomy for Lumbar Spinal Stenosis: A Post Hoc Analysis of a Multicenter Randomized Clinical Trial”
Raj, S., & Goni, V. G. (2026) · Global Spine Journal · doi:10.1177/21925682261491295
Personalizing rehabilitation approaches: Moderator analyses of manual therapy and exercise effectiveness in individuals with chronic neck pain: Secondary analysis of the SS-MECH trial
Cook, C. E., McDevitt, A. W., Clewley, D. J., O'Halloran, B. J., Learman, K., Keter, D. L., Rossettini, G., & Keefe, F. (2026) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2026.103665

Authors: Kent, D. M., Rothwell, P. M., Ioannidis, J. P., Altman, D. G., & Hayward, R. A.
Affiliations: Tufts Medical Center (US)
John Radcliffe Hospital (GB)
University of Oxford (GB)
University of Michigan (US)
Corresponding author: Kent, David M
ORCID: Kent, David M
Rothwell, Peter M
Ioannidis, John PA
Hayward, Rodney A
Venue: Trials
Publisher: Springer Science and Business Media LLC
Published: 2010-08-12
Volume: 11
Issue: 1
Pages: 85-85
ISSN: 1745-6215 (ISSN-L)
DOI: 10.1186/1745-6215-11-85
PMC: PMC2928211
OpenAlex: W2128780239
Cited by: 504
References: 72
Citations by year: 2026: 32 · 2025: 20 · 2024: 33 · 2023: 26 · 2022: 25 · 2021: 43 · 2020: 32 · 2019: 42 · 2018: 36 · 2017: 37 · 2016: 41 · 2015: 31 · 2014: 39 · 2013: 15 · 2012: 28
FWCI: 17.70
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/2.0 (tdm)
Locations: Trials (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders: Pfizer
National Institutes of Health (P60DK20572)
Quality Enhancement Research Initiative
National Institute of Diabetes and Digestive and Kidney Diseases (P60DK020572, P60 DK 20572)
National Institute of Neurological Disorders and Stroke (R01NS062153)
National Center for Research Resources (U54 RR023562)
Topics: Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
Physical Sciences › Mathematics › Statistics and Probability › Advanced Causal Inference Techniques
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Meta-analysis and systematic reviews
Keywords: treatment effect heterogeneity, subgroup analysis, clinical trial reporting, treatment risks and benefits, risk stratification
MeSH terms: Clinical Trials as Topic, Humans, Risk Factors, Therapeutics, Reproducibility of Results, Multivariate Analysis, Risk Assessment, Evidence-Based Medicine

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks